SCHEMBL1161574

SCHEMBL1161574

Cn1c(=O)oc2cc(CBr)ccc21

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKM P14618 5/20 0.49
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 2/20 0.48
HSD17B10 Q99714 1/20 0.48
PDE10A Q9Y233 2/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
POLB P06746 1/20 0.46
HTR1A P08908 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8109023 0.87 ALDH1A1 (0.50) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL29490178 0.87 DDB1 (0.46) ALDH1A1KDM4EHPGDMAPK1HSD17B10
SCHEMBL1161591 0.87 DDB1 (0.46) ALDH1A1KDM4EHPGDMAPK1HSD17B10
SCHEMBL10081599 0.85 PKM (0.57) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL10393719 0.84 HTR1A (0.51) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL2154696 0.83 ALDH1A1 (0.52) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL13156347 0.83 PKM (0.49) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL2112483 0.83 KDM4E (0.56) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL8109737 0.83 HTR1A (0.53) PKMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL14470171 0.83 PKM (0.46) PKMALDH1A1L3MBTL1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021002986-A2 BAX INHIBITORS AND USES THEREOF CASE WESTERN RESERVE UNIVERSITY (US) 2021-01-07 WO disclosed
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed
EP-0462831-B1 Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase ZENECA LTD (GB) 1996-02-28 EP disclosed
US-5462953-A Benzoxazolyl derivatives useful as 5-lipoxygenase inhibitors IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-10-31 US disclosed
US-5364877-A Antiinflammatory agents, antiallergens ICI PHARMA (GB) 1994-11-15 US disclosed
US-5278177-A Enzyme inhibitory IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-11 US disclosed
US-5179115-A Antiinflammatory agents, antiallergens IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-01-12 US disclosed
EP-0462831-A2 Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase ZENECA LIMITED (GB) 1991-12-27 EP disclosed